Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Operating Leases (2022 - 2025)

Cellebrite DI (CLBT) has 2 years of Operating Leases data on record, last reported at $9.2 million in Q4 2023.

  • For Q4 2023, Operating Leases fell 11.55% year-over-year to $9.2 million; the TTM value through Dec 2023 reached $9.2 million, down 11.55%, while the annual FY2023 figure was $9.2 million, 11.55% down from the prior year.
  • Operating Leases reached $9.2 million in Q4 2023 per CLBT's latest filing, down from $10.4 million in the prior quarter.
  • Across five years, Operating Leases topped out at $10.4 million in Q4 2022 and bottomed at $9.2 million in Q4 2023.